Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Gravina

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Anticancer Research|February 24, 2001
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell lineC Festuccia, G L Gravina, A Angelucci, et al.
Clinical & Experimental Metastasis|March 10, 2001
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell linesA Angelucci, S D'Ascenzo, C Festuccia, et al.
Andrology|August 9, 2017
Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysisE Limoncin, G L Gravina, G Corona, et al.
International Journal of Cancer|April 21, 1999
Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix componentsC Festuccia, M Bologna, G L Gravina, et al.
Biomed Research International|June 28, 2014
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancerA Irelli, G Bruera, K Cannita, et al.
International Journal of Cancer|February 1, 2000
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cellsC Festuccia, A Angelucci, G L Gravina, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2015
Squamous cell carcinoma of the rectum: The treatment paradigmD Musio, F De Felice, S Manfrida, et al.
Endocrine-Related Cancer|December 3, 2005
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell linesC Festuccia, P Muzi, D Millimaggi, et al.
The Thoracic and Cardiovascular Surgeon|June 5, 2007
Foreign bodies aspirated in children: role of bronchoscopyD Divisi, S Di Tommaso, M Garramone, et al.
International Journal of Impotence Research|September 20, 2013
The sexual attraction toward disabilities: a preliminary internet-based studyE Limoncin, R Carta, G L Gravina, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Anticancer Research|February 24, 2001
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell lineC Festuccia, G L Gravina, A Angelucci, et al.
Clinical & Experimental Metastasis|March 10, 2001
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell linesA Angelucci, S D'Ascenzo, C Festuccia, et al.
Andrology|August 9, 2017
Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysisE Limoncin, G L Gravina, G Corona, et al.
International Journal of Cancer|April 21, 1999
Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix componentsC Festuccia, M Bologna, G L Gravina, et al.
Biomed Research International|June 28, 2014
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancerA Irelli, G Bruera, K Cannita, et al.
International Journal of Cancer|February 1, 2000
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cellsC Festuccia, A Angelucci, G L Gravina, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2015
Squamous cell carcinoma of the rectum: The treatment paradigmD Musio, F De Felice, S Manfrida, et al.
Endocrine-Related Cancer|December 3, 2005
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell linesC Festuccia, P Muzi, D Millimaggi, et al.
The Thoracic and Cardiovascular Surgeon|June 5, 2007
Foreign bodies aspirated in children: role of bronchoscopyD Divisi, S Di Tommaso, M Garramone, et al.
International Journal of Impotence Research|September 20, 2013
The sexual attraction toward disabilities: a preliminary internet-based studyE Limoncin, R Carta, G L Gravina, et al.
Pageof 3